FDA Issues Draft Guidance on Good Clinical Practice in Ongoing Clinical Trial Modernization Efforts (JSON)

lexblog.com/lib/JGA26R7Fview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Issues Draft Guidance on Good Clinical Practice in Ongoing Clinical Trial Modernization Efforts",
    "url": "https://www.lexblog.com/2023/06/09/fda-issues-draft-guidance-on-good-clinical-practice-in-ongoing-clinical-trial-modernization-efforts/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-JGA26R7F",
        "url": "https://www.lexblog.com/lib/JGA26R7F/"
    },
    "datePublished": "2023-06-09T17:24:19-04:00",
    "dateModified": "2023-06-09T14:24:36-04:00",
    "author": {
        "@type": "Person",
        "name": "Kevin Madagan, Sarah Thompson Schick"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=26092",
    "sourceStability": "may-move"
}